Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Mar 24, 2023
Document Date
Mar 23, 2023
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.